ORIG3N

ORIG3N is a biotechnology company dedicated to breakthrough treatments for rare genetic diseases, targeting cardiac, hepatic, and neurodegenerative disorders. These therapies are based on Nobel Prize-winning technology, replacing the trial-and-error approach in disease treatment and enabling longer, healthier lives.